Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chow

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|July 21, 2016
5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved PropertiesTodd J Kohn, Xiaohui Du, SuJen Lai, et al.
Nature|September 24, 2020
Synthetic group A streptogramin antibiotics that overcome Vat resistanceQi Li, Jenna Pellegrino, D John Lee, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase ActivatorsXiaohui Du, Ronald J Hinklin, Yumei Xiong, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry|April 25, 2012
Structure-based design of novel inhibitors of the MDM2-p53 interactionYosup Rew, Daqing Sun, Felix Gonzalez-Lopez De Turiso, et al.
Journal of Medicinal Chemistry|February 20, 2014
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interactionAna Z Gonzalez, John Eksterowicz, Michael D Bartberger, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|July 21, 2016
5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved PropertiesTodd J Kohn, Xiaohui Du, SuJen Lai, et al.
Nature|September 24, 2020
Synthetic group A streptogramin antibiotics that overcome Vat resistanceQi Li, Jenna Pellegrino, D John Lee, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase ActivatorsXiaohui Du, Ronald J Hinklin, Yumei Xiong, et al.
Journal of Medicinal Chemistry|March 8, 2014
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteresAna Z Gonzalez, Zhihong Li, Hilary P Beck, et al.
Journal of Medicinal Chemistry|April 25, 2012
Structure-based design of novel inhibitors of the MDM2-p53 interactionYosup Rew, Daqing Sun, Felix Gonzalez-Lopez De Turiso, et al.
Journal of Medicinal Chemistry|February 20, 2014
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interactionAna Z Gonzalez, John Eksterowicz, Michael D Bartberger, et al.
Pageof 5